When life poses a challenge, Jatin Mahajan is not the sort of person who will skirt responsibility. Jatin believes in leading from the front, and facing challenges and responsibilities head-on.

Jatin Mahajan is the managing director of J Mitra & Company – global leader in in-vitro diagnostics (IVD) segment within the overall healthcare space. This 50-year old organisation has grown from strength to strength, identifying the changing business dynamics and adapting and innovating to meet the ever-changing needs of the masses.

J Mitra & Company has been steadfast in its dominance of the IVD segment, not just in India, but across the overall international arena. It is present across all the continents, and its presence includes in regions like – Europe, Latin America, Middle-East, Africa, SAARC, South-East Asia – in over 45 countries.

Jatin Mahajan is the person responsible for spearheading the phenomenal growth and international forays for the last 18-years, and has steered the company to its present glory – regional leader, exporter to over 45 countries, and having more than 55 patents.

Jatin is a well-established name in the medical fraternity as a promoter of excellent quality medical diagnostic test solutions for the detection of various infectious diseases. A regular speaker at Industry forums like ASSOCHAM, AIMED and Voice of Health, Jatin is an MBA from the renowned International Management Institute, New Delhi. His cost-effective, safe, and international-standards compliant products are used by most of the big names globally, and his clientele reads like a who’s who of the medical diagnostic fraternity. It is Jatin’s drive for quality and excellence that has resulted in J Mitra & Company bagging more than 55 patents in this industry, and the title of “India’s Patent King” by Wall Street Journal.

Jatin Mahajan’s journey has been quite exciting, eventful and satisfying. J Mitra’s Diagnostics business was started by the visionary Shri Lalit Mahajan (Jatin’s father) in 1969. When the company was incorporated, all such diagnostic requirements were managed through imported solutions. Lalit Mahajan established J Mitra & Company as the leading IVD company in India. As the economy grew and liberalisation happened, they realised that the rules and regulations in the country were not in favour of home-grown companies. It was at this juncture that Jatin Mahajan was mandated to drive the next growth impetus for the company. Reigns of the company shifted to Jatin Mahajan, and he undertook the onerous task of taking the company fully global, to carve out newer markets so that the onset of relatively cheaper (though at times, lesser quality) imported diagnostic products would not hamper their growth.

Jatin focused on enhancing and consolidating the company’s international presence, and currently they are one of the leading exporters of IVD solutions from India. Under Jatin, the company focused on extensive R&D and innovations to further reduce the cost price of their diagnostic solutions. J Mitra & Company was successful in matching their pricing with the imported IVD solutions in spite of the cost disadvantage that they faced on account of the higher duty on imported raw material.

Most people would associate reduction in pricing to an automatic reduction in quality, but this is not the case with J Mitra & Company. The company is synonymous with the highest quality standard in the industry globally, and its quality assurance certifications include – TUV SUD Certification, ICMED 13485, ISO 9001:2015, EN ISO 13485:2016, WHO-GMP and CE

Jatin truly believes that change is the only constant, and substantial organizational growth can be driven only through constant innovation and adapting the latest business enhancement tools.

As a charismatic business transformation catalyst, Jatin has focused and enhance all aspects of his business processes and lifecycle. The unflinching focus on R&D led to the launch of iQuant in the Indian market. Launched in August 2018, iQuant is India’s first portable diagnostic solution, in collaboration with IIT Madras’ HTIC (Healthcare Technology Innovation Centre), this portable device is a state-of-the-art Fluorescence Immunoassay Analyzer for quantitative and qualitative determination of 9 blood test parameters – that includes TSH (Thyroid Stimulating Hormone), T3 (Tri-iodo thyronine), T4 (Thyroxin), Vitamin D, Dengue NS1 Antigen, Dengue IgM, Dengue IgG, HbA1c and CRP test. With this launch, various highly-active and sought-after diagnostic solutions have become available across the country and in the remotest of locations at the fraction of a cost. iQuant is an innovative mix – on the product side, it is a mix of science, IT, healthcare and research, while on the implementation side it is great combination of social conditions, ground realities coupled with business sense.

This is an innovative, path-breaking product that will greatly influence the detection and diagnostic process, which will hasten the treatment and cure process – resulting in a healthier India, in line with government’s healthcare-for-all initiative.

Recently, J Mitra & Company has also launched two other products – the Celiac Card and the Malaria Ag Microlisa test.

J Mitra & Company is the only Indian company manufacturing Celiac detection kit for Rapid and Elisa tests in collaboration with AIIMS-ICGEB-THSTI    and sponsored by Department of Biotechnology, Government of India.

To meet the onslaught of the international biggies, Jatin made his own systems and processes very sound and robust – aggressive automation to mitigate the risks of human error; focusing on enhancing the CRM to keep complete tabs on customer requirements and pain areas; a robust logistics system that ensures minimal time lag between production and delivery to end-customer, thus reducing the need for extensive storage facilities as well as mitigating the losses that happen at warehouses. Working with external consultants, J Mitra & Company has a very stringent audit and reporting mechanism that not only highlights impending issues, but also ensures that performance enhancements are driven at all levels. The Company continue to identify the industry best practices, and ensure its implementation and adherence within their organisation. They have continued to focus on their people’s wellbeing and progress, and they have continued to be the champions within the organisation driving its continuous and steadfast growth. Marketing has been another key focus area. They continue to expand into newer markets while further consolidating their presence in the existing ones. They continue to maintain close connects with the clientele, understanding their needs, and endeavour to address them as much as possible.

The five most important words are – innovation, affordability, accessibility, quality and speed. While on one hand, the company is focused on decreasing the cost and timeframe for detection of ailments, on the other they are focusing on extensive R&D so as to develop newer solutions for other ailments -the focus is on better, faster and more extensive diagnostics.

Jatin Mahajan & J Mitra & Company has been constantly focusing on positively impacting human lives, ensuring that the distance between patients and point-of-care constantly declines and diagnostics reach the absolute last mile.